{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:08:37Z","timestamp":1777486117764,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.hoc.2025.12.006","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T12:45:08Z","timestamp":1770381908000},"page":"231-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of Classic Hodgkin Lymphoma in Pregnancy"],"prefix":"10.1016","volume":"40","author":[{"given":"Michael A.","family":"Spinner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjana H.","family":"Advani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11899-013-0163-4","article-title":"Hodgkin lymphoma in pregnancy","volume":"8","author":"Bachanova","year":"2013","journal-title":"Curr Hematol Malig Rep"},{"issue":"19","key":"10.1016\/j.hoc.2025.12.006_bib2","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.2019000961","article-title":"How I treat lymphoma in pregnancy","volume":"136","author":"Dunleavy","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib3","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.2009.23.2801","article-title":"Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes","volume":"28","author":"Van Calsteren","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9815","key":"10.1016\/j.hoc.2025.12.006_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0140-6736(11)61348-2","article-title":"Haematological cancers in pregnancy","volume":"379","author":"Brenner","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/AOG.0b013e3182a057a2","article-title":"Incidence of pregnancy-associated cancer in Denmark, 1977\u20132006","volume":"122","author":"Eibye","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.hoc.2025.12.006_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/JCO.2008.17.4110","article-title":"Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study","volume":"27","author":"Stensheim","year":"2009","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.hoc.2025.12.006_bib7","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1200\/JCO.2013.49.8220","article-title":"Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis","volume":"31","author":"Evens","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2025.12.006_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/jamaoncol.2016.1396","article-title":"Maternal and fetal outcomes after therapy for hodgkin or non-hodgkin lymphoma diagnosed during pregnancy","volume":"2","author":"Pinnix","year":"2016","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2025.12.006_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2015.62.4445","article-title":"Hematologic malignancies in pregnancy: management guidelines from an International Consensus Meeting","volume":"34","author":"Lishner","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.hoc.2025.12.006_bib10","first-page":"1","article-title":"Cancer diagnosis during pregnancy and the postpartum period: impact on well-being and mental health","author":"Farhana","year":"2025","journal-title":"Women\u2019s Reproductive Health"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2025.12.006_bib11","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/hon.3150","article-title":"Lymphomas in pregnancy","volume":"41","author":"Pirosa","year":"2023","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.hoc.2025.12.006_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070486","article-title":"Making decisions about radiological imaging in pregnancy","author":"Wiles","year":"2022","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.hoc.2025.12.006_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2214\/AJR.10.4271","article-title":"Body CT during pregnancy: utilization trends, examination indications, and fetal radiation doses","volume":"196","author":"Goldberg-Stein","year":"2011","journal-title":"Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.hoc.2025.12.006_bib14","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2967\/jnumed.117.195404","article-title":"New fetal radiation doses for 18F-FDG based on human data","volume":"58","author":"Zanotti-Fregonara","year":"2017","journal-title":"J Nucl Med"},{"issue":"5","key":"10.1016\/j.hoc.2025.12.006_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2967\/jnumed.109.071878","article-title":"Absorbed 18F-FDG dose to the fetus during early pregnancy","volume":"51","author":"Zanotti-Fregonara","year":"2010","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib16","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1097\/AOG.0000000000002355","article-title":"Committee opinion No. 723: guidelines for diagnostic imaging during pregnancy and lactation","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.6004\/jnccn.2022.0021","article-title":"NCCN guidelines\u00ae insights: Hodgkin Lymphoma, version 2.2022","volume":"20","author":"Hoppe","year":"2022","journal-title":"J Natl Compr Cancer Netw"},{"issue":"25","key":"10.1016\/j.hoc.2025.12.006_bib18","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2025.12.006_bib19","doi-asserted-by":"crossref","first-page":"vi160","DOI":"10.1093\/annonc\/mdt199","article-title":"Cancer, pregnancy and fertility: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Peccatori","year":"2013","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2025.12.006_bib20","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.006","article-title":"Treatment of early stages hodgkin lymphoma during pregnancy","volume":"10","author":"Avil\u00e9s","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"10.1016\/j.hoc.2025.12.006_bib21","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2352-3026(19)30195-4","article-title":"Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study","volume":"6","author":"Maggen","year":"2019","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.12.006_bib22","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjh.18727","article-title":"The clinical features, management and outcomes of lymphoma in pregnancy: a multicentre study by the Australasian Lymphoma Alliance","volume":"201","author":"Di Ciaccio","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.hoc.2025.12.006_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104482","article-title":"Management of Hodgkin Lymphoma during pregnancy, review of the literature and description of an homogenous expectative attitude associated with excellent outcome","volume":"203","author":"Hag\u00e8ge","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"10.1016\/j.hoc.2025.12.006_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1470-2045(04)01466-4","article-title":"Use of chemotherapy during human pregnancy","volume":"5","author":"Cardonick","year":"2004","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2025.12.006_bib25","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3109\/00016349.2010.512070","article-title":"Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study","volume":"89","author":"Van Calsteren","year":"2010","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib26","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2206125","article-title":"Overall survival with Brentuximab vedotin in stage III or IV hodgkin\u2019s lymphoma","volume":"387","author":"Ansell","year":"2022","journal-title":"N Engl J Med"},{"issue":"15","key":"10.1016\/j.hoc.2025.12.006_bib27","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1056\/NEJMoa2405888","article-title":"Nivolumab+AVD in advanced-stage classic Hodgkin\u2019s lymphoma","volume":"391","author":"Herrera","year":"2024","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.hoc.2025.12.006_bib28","first-page":"276","article-title":"High expression of the CD30 molecule in human decidual cells","volume":"145","author":"Ito","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.hoc.2025.12.006_bib29","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3389\/fimmu.2020.01023","article-title":"Role of regulatory T cells in regulating fetal-maternal immune tolerance in healthy pregnancies and reproductive diseases","volume":"11","author":"Huang","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2025.12.006_bib30","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/eji.201948382","article-title":"Immune checkpoint molecules in pregnancy: focus on regulatory T cells","volume":"50","author":"Zhang","year":"2020","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.hoc.2025.12.006_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/bdrb.21176","article-title":"An evaluation of the impact of PD-1 pathway blockade on reproductive safety of therapeutic PD-1 inhibitors","volume":"107","author":"Poulet","year":"2016","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"issue":"19","key":"10.1016\/j.hoc.2025.12.006_bib32","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa2308135","article-title":"Severe immune-related enteritis after in utero exposure to pembrolizumab","volume":"389","author":"Baarslag","year":"2023","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5625","article-title":"Immune checkpoint inhibitor use during pregnancy and outcomes in pregnant individuals and newborns","volume":"7","author":"Gougis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hoc.2025.12.006_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100831","article-title":"Novel agents for the treatment of lymphomas during pregnancy: a comprehensive literature review","volume":"49","author":"Luttwak","year":"2021","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.hoc.2025.12.006_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0889-8545(05)70006-1","article-title":"Radiation therapy during pregnancy","volume":"25","author":"Mayr","year":"1998","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0167-8140(02)00329-8","article-title":"Radiotherapy of Hodgkin\u2019s disease in early pregnancy: embryo dose measurements","volume":"66","author":"Mazonakis","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.hoc.2025.12.006_bib37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejmp.2017.09.130","article-title":"Estimation and reduction of the radiation dose to the fetus from external-beam radiotherapy","volume":"43","author":"Mazonakis","year":"2017","journal-title":"Phys Med"},{"issue":"6","key":"10.1016\/j.hoc.2025.12.006_bib38","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.13180","article-title":"Association of chemotherapy timing in pregnancy with congenital malformation","volume":"4","author":"van Gerwen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.hoc.2025.12.006_bib39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7326\/0003-4819-61-108","article-title":"Vinblastine sulfate in Hodgkin\u2019s disease in pregnancy","volume":"61","author":"Rosenzweig","year":"1964","journal-title":"Ann Intern Med"},{"issue":"3607","key":"10.1016\/j.hoc.2025.12.006_bib40","first-page":"703","article-title":"Vinblastine sulfate treatment of Hodgkin\u2019s disease during a pregnancy","volume":"143","author":"Armstrong","year":"1964","journal-title":"Science (1979)"},{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib41","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJMoa0706475","article-title":"Long-term medical and social consequences of preterm birth","volume":"359","author":"Moster","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.hoc.2025.12.006_bib42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJMra2303347","article-title":"Defining the neurologic consequences of preterm birth","volume":"389","author":"Inder","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.hoc.2025.12.006_bib43","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1182\/bloodadvances.2023010090","article-title":"An international real-world analysis of relapsed\/refractory lymphoma occurring during pregnancy","volume":"7","author":"Farooq","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.hoc.2025.12.006_bib44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/ajh.26527","article-title":"Checkpoint inhibitor immunotherapy during pregnancy for relapsed-refractory Hodgkin lymphoma","volume":"97","author":"Evens","year":"2022","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.hoc.2025.12.006_bib45","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.hoc.2025.12.006_bib46","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1056\/NEJMoa0807154","article-title":"The safety of metoclopramide use in the first trimester of pregnancy","volume":"360","author":"Matok","year":"2009","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib47","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/AOG.0000000000000479","article-title":"Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy","volume":"124","author":"Oliveira","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1016\/j.hoc.2025.12.006_bib48","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/annonc\/mdz228","article-title":"Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting","volume":"30","author":"Amant","year":"2019","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2025.12.006_bib49","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06598.x","article-title":"G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis","volume":"137","author":"Evens","year":"2007","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2025.12.006_bib50","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3324\/haematol.2013.099101","article-title":"Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutropenia International Registry","volume":"99","author":"Zeidler","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2025.12.006_bib51","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/AOG.0000000000000602","article-title":"Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia","volume":"125","author":"Boxer","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"02","key":"10.1016\/j.hoc.2025.12.006_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4236\/jct.2012.32021","article-title":"The use of neupogen (Filgrastim) or neulasta (Pegfilgrastim) during pregnancy when chemotherapy is indicated for maternal cancer treatment","volume":"03","author":"Cardonick","year":"2012","journal-title":"J Cancer Ther"},{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib53","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/humrep\/dey393","article-title":"Recombinant human granulocyte-colony stimulating factor in women with unexplained recurrent pregnancy losses: a randomized clinical trial","volume":"34","author":"Eapen","year":"2019","journal-title":"Hum Reprod"},{"issue":"8","key":"10.1016\/j.hoc.2025.12.006_bib54","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/annonc\/mdz168","article-title":"Thrombosis as a treatment complication in Hodgkin lymphoma patients: a comprehensive analysis of three prospective randomized German Hodgkin Study Group (GHSG) trials","volume":"30","author":"Borchmann","year":"2019","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2025.12.006_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/1471-0528.17347","article-title":"Maternal and perinatal outcomes following a diagnosis of Hodgkin lymphoma during or prior to pregnancy: a systematic review","volume":"130","author":"Houlihan","year":"2023","journal-title":"BJOG"},{"issue":"17","key":"10.1016\/j.hoc.2025.12.006_bib56","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"22","key":"10.1016\/j.hoc.2025.12.006_bib57","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/bloodadvances.2018024802","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy","volume":"2","author":"Bates","year":"2018","journal-title":"Blood Adv"},{"issue":"11","key":"10.1016\/j.hoc.2025.12.006_bib58","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1016\/S2352-3026(24)00288-6","article-title":"Maternal and obstetric outcomes in women with pregnancy-associated haematological malignancies: an observational nationwide cohort study","volume":"11","author":"Pinson","year":"2024","journal-title":"Lancet Haematol"},{"issue":"19","key":"10.1016\/j.hoc.2025.12.006_bib59","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1056\/NEJMoa1508913","article-title":"Pediatric outcome after maternal cancer diagnosed during pregnancy","volume":"373","author":"Amant","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2025.12.006_bib60","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S1470-2045(11)70363-1","article-title":"Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study","volume":"13","author":"Amant","year":"2012","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2025.12.006_bib61","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1080\/09297049.2021.1902489","article-title":"Long-term neurodevelopmental outcome after prenatal exposure to maternal hematological malignancies with or without cytotoxic treatment","volume":"27","author":"van Gerwen","year":"2021","journal-title":"Child Neuropsychol"},{"issue":"1","key":"10.1016\/j.hoc.2025.12.006_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clml.2015.09.009","article-title":"Speckle-tracking echocardiography to detect cardiac toxicity in children who received anthracyclines during pregnancy","volume":"16","author":"Avil\u00e8s","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858825001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T21:25:40Z","timestamp":1773955540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858825001479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0889858825001479"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2025.12.006","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of Classic Hodgkin Lymphoma in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2025.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}